Call for Abstract
2nd World Congress on Rare Diseases , will be organized around the theme “Hope: The Best Therapy for Rare Diseases”
World Rare Diseases 2019 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in World Rare Diseases 2019
Submit your abstract to any of the mentioned tracks.
Register now for the conference by choosing an appropriate package suitable to you.
A Rare disease is any disease that influences a very less number of the population. Rare illnesses include rare cancers such as childhood cancers and a few other well-known conditions, such as cystic fibrosis and Huntington’s disease. The vast majority of rare infections will affect far less than this – a few will affect only a handful, or even a single individual. This is the case of thalassemia, anaemia of genetic origin, which is rare in Northern Europe, but it is frequent in the Mediterranean region. Many rare diseases appear early in life. The exact cause for many rare diseases remains unknown. But Environmental factors, viral infections, genetic mutations, diet, smoking, or exposure to chemicals, also can play a role in rare diseases.
- Track 1-1Cure vs care
- Track 1-2Resources for discovering treatments
- Track 1-3Community unity
- Track 1-4Patients group
Due to the rarity and differences of rare infections, research needs to be worldwide to guarantee that specialists, researchers and clinicians are connected, that clinical trials are multinational and that patients can benefit from the pooling of resources over borders. It is still a reality for rare disease patients to spend a long time within the health care system before an exact conclusion is made. Research in rare infections is crucial as many patients still need proper diagnosis and left without compelling medications; it is also an region where expertise is also rare. In addition, research in this region is exceptionally significant from the scientific point of view as rare diseases are model diseases for more common disorders and are strong drivers of innovation. Next-generation sequencing and progressed information sharing have resulted in faster discovery of gene disease and thus diagnostics .
- Track 2-1Patient access to diagnosis
- Track 2-2Rare disease mechanism discovery
- Track 2-3Therapeutic development
Focusing within the coordination between medical, social and support services in order to handle the challenges that people living with a rare disease and their families around the world confront each day. Even if rare disease patients and their families face many challenges, enormous progress is being made every day. Most rare diseases have no cure, so living with a rare infection is an on-going learning experience for patients and families. Day-by-day, hand-in-hand, together we present a united voice to advocate for the treatments, care, resources and services we all need. Managing these care-related tasks alongside their usual daily activities such as work, school and leisure time can be challenging.
- Track 3-1Patient attrition
- Track 3-2Diagnosis
- Track 3-3Developing and using orphan medicinal products
- Track 3-4Access the treatment
Drugs that are not developed by the pharmaceutical industry for economic reasons but which respond to public health need. Orphan drugs' are intended to treat diseases so rare that sponsors are reluctant to develop them under regular marketing conditions. The process from the discovery of a new molecule to its marketing is long, expensive and very uncertain. Developing a drug expecting to treat a rare disease does not allow the recovery of the capital invested for its research.
Many terms are normally used in describing the infectious diseases. Disease refers to the presence of pathology and an infectious disease is an infection caused by a microorganism. Virulence is a term referring to the power of an organism to produce disease in a particular host. Immunity refers to the degree of resistance of the host for a specific microbe. Many infectious maladies, such as measles and chickenpox, can be anticipated by vaccines. Infectious diseases can cause many distinctive symptoms. Some are so mild that you may not even notice any side effects, while others can be life-threatening. There are medicines for a few infectious diseases, but for others, such as a few viruses, you can only treat your symptoms. You can take steps to prevent many infectious maladies. There are numerous distinctive ways that you can get an infectious disease for example – through insect or animal bites, contaminated food, and water. Pregnant mothers can too pass some germs along to their babies; the infectious diseases are usually characterized by the dominant organ system involved.
- Track 5-1Bacterial infection
- Track 5-2Viral infections
- Track 5-3Fungal infection
- Track 5-4Diagnosis - imaging scans, biopsies
There are numerous different causes of rare diseases. The larger part is thought to be hereditary, directly caused by changes in genes or chromosomes. In a few cases, genetic changes that cause disease are passed from one generation to the next. In other cases, they occur randomly in a person who is the primary in a family to be diagnosed. These diseases have terrible names. Sometimes they are even nameless. Due to the lack of investment in research, we are still new with the causes or components of most of the rare genetic diseases scientifically known to exist. Chromosome disorders are of two types numerical and structural. In some cases chromosome abnormalities happen during the development of an egg or sperm cell, and other times they happen after conception. Chromosome disorders may be suspected in people who have developmental delays, intellectual disabilities and/or physical abnormalities.
- Track 6-1Metabolic disorder
- Track 6-2Chromosome abnormality
- Track 6-3Fabry diseases
- Track 6-4Turner syndrome
- Track 6-5Chromosomal duplications
- Track 6-6Chromosomal deletions
Neglected tropical diseases are a bunch of parasitic and bacterial infections that affect more than including 1 billion people and cost developing economies billions of dollars each year, 836 million children. They are as regularly as possible clustered together topographically and people are habitually afflicted with more than one parasite or contamination. Successful control can be accomplished when chosen open wellbeing approaches are combined and passed on locally. Trade are guided by the local epidemiology and the accessibility of fitting measures to recognize, expect and control maladies. Various dismissed tropical maladies can be expected, disposed of or indeed demolished with made strides get to to existing secure and cost-effective gadgets. Control depends on straightforward mediations that can be carried out by non-specialists too.
- Track 7-1Schistosomiasis
- Track 7-2Ascariasis
- Track 7-3Onchocerciasis
- Track 7-4Fascioliasis
Rare pediatric diseases is a serious or life-threatening disease, affect people aged from birth to 18 years, including age groups often called neonates, infants, children, and adolescents. Achondrogenesis is one of the cases of pediatric rare diseases. Pediatric rare diseases have received increased attention in recent years due to greater public awareness, significantly improved understanding and treatment of the relatively more common disorders, elimination of nutritional deficiencies and the development of laws related to the treatment of rare diseases.
- Track 8-1Steroid
- Track 8-2Drug treatment
- Track 8-3Clinical trials
There are many rare endocrine system diseases. Addison's infection is very uncommon. . According to the National Organizing of Wellbeing, more than 175 distinct rare diseases affect the endocrine system, a complex system of organs and glands that employs around 30 distinctive hormones to influence a range of vital functions including growth, metabolism, heart function, and fertility. Rare endocrine diseases can potentially affect any organ system, however.
- Track 9-1Rare hormonal disorders
- Track 9-2Graves disease
- Track 9-3Addisons disease
- Track 9-4Thyroid cancer
Rare hematology diseases fall into various subcategories, including anemia-type red blood cell conditions (e.g. sickle cell beta thalassemia, Diamond-Blackfan anemia), white blood cell dysfunctions related with different malignancies ,immuno- platelet-based abnormalities that influence platelet and plasma cell disorder. Some rare blood disorders especially those that are gene-based are simple to distinguish with a basic test, whereas others require significant investigator work to effectively analyze. Due to the expansive number of blood conditions common and exceptional, haematologists tend to be gifted agents since they got to be pros in differential conclusion.
- Track 10-1Sickle cell diseases
- Track 10-2Anemia-type red blood cell
- Track 10-3White blood cell
- Track 10-4Immuno-disorders
- Track 10-5Plasma-based diseases
Most of the diseases influences the skin begin within the layers of the skin, such abnormalities are also important factors in the diagnosis of a variety of internal diseases. The skin has an inherent region-specific anatomical diversity which will profoundly modify the appearance of a rash. This is apparent when skin transplanted from one area of the body to another retains the morphological characteristics of the donor area. The classification of hereditary skin disorders generally has been based upon gross morphological, histological and electron microscopic findings; however, because a skin disease may not always have a characteristic presentation, the specific diagnosis sometimes has been in doubt. For example Aarskog
Both national and international association have been made in later years to inform and defend patients affected by these disorders. Rare infections occurs due to changes in the immune system represent a field of medical science of great interest that is undergoing continuous expansion; these disorders have an incredible social and economic impact because they often affect young or very young people at the height of their social activities and relationships. Achondroplasia is a disorder of bone growth that prevents the changing of cartilage to bone. It is characterized by dwarfism, limited range of motion at the elbows, and normal intelligence. Most cases of achondroplasia are not inherited. Approximately 80% of people who have achondroplasia have parents with normal stature and are born with the condition as a result of a new gene alteration. Each person with Achondroplasia has a 50% chance, with each pregnancy, to pass on the changed quality.
- Track 12-1Steroid
- Track 12-2PANDAS
- Track 12-3Scleroderma
Rare diseases give the opportunities to study human physiology and biomedical science from interesting perspectives. Major scientific breakthroughs resulting from study of rare diseases. Researchers are increasingly working through networks in order to share the results of their research and to advance more effectively. The satisfaction of diagnosing a patient with a rare disorder successfully is often rapidly countered by the realization that the capacity to understand and treat the patient’s condition is limited by ignorance and the difficulties of studying the disease. An orphan drug is a medicinal product developed for the treatment of rare diseases. For all rare diseases, science can provide some answers.
- Track 13-1Orphan products clinical Trials Grants Program
- Track 13-2Rexin G
- Track 13-3Research on new drugs
- Track 13-4Biomedical
Rare diseases affect an estimated 2-4% of the population. A likely next step is whole genome sequencing, a diagnostic technique that over the last decade has significantly bolstered the effort to identify undiscovered diseases. A different approach is to search for patients with similar hereditary abnormalities and similar side effects. Determining the cause of a malady is often a victory in its own right for people who’ve spent years trying to figure out what’s wrong with their bodies.
- Track 14-1Exome
- Track 14-2Mystery illness program
- Track 14-3Rarity of the condition or disease